Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/64745
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Franco Fernández, Rafael | - |
dc.date.accessioned | 2015-04-07T15:33:39Z | - |
dc.date.available | 2015-04-07T15:33:39Z | - |
dc.date.issued | 2014-12-16 | - |
dc.identifier.issn | 1662-5137 | - |
dc.identifier.uri | http://hdl.handle.net/2445/64745 | - |
dc.description.abstract | As the title of the special issue indicates, controversy surrounds augmentation of brain cognition in humans. Lacking efficacious drugs for Alzheimer's disease (AD) and with many AD patients recruited for clinical trials that unfortunately do not provide the expected results, one wonders whether to test cognition enhancement strategies in individuals without symptoms of cognition decline. This opinion article presents the view that safe drugs and or dietary supplements should be tested worldwide in aged individuals under the control of a non-for-profit organization. | - |
dc.format.extent | 3 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Frontiers | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.3389/fnsys.2014.00240 | - |
dc.relation.ispartof | Frontiers in systems Neuroscience, 2014, vol. 8, p. 1-3 | - |
dc.relation.uri | http://dx.doi.org/10.3389/fnsys.2014.00240 | - |
dc.rights | cc-by (c) Franco Fernández, Rafael, 2014 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) | - |
dc.subject.classification | Malaltia d'Alzheimer | - |
dc.subject.classification | Genètica humana | - |
dc.subject.classification | Vitamina C | - |
dc.subject.classification | Inhibidors de fosfodiesterases | - |
dc.subject.other | Alzheimer's disease | - |
dc.subject.other | Human genetics | - |
dc.subject.other | Vitamin C | - |
dc.subject.other | Phosphodiesterase Inhibitors | - |
dc.title | Enhancing cognition before clinical symptoms of dementia. | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 649521 | - |
dc.date.updated | 2015-04-07T15:33:39Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 25565993 | - |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
649521.pdf | 590.16 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License